Johnson plans to increase investment in Ken-Ya within NT$350 million, aiming for board seats and M&A declaration
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Johnson announced its plan to increase its investment in Ken-Ya, aiming to secure board seats and potentially pursue M&A, to integrate their complementary strengths in R&D, distribution, and technology. Ken-Ya also announced a stock split plan.
AI Analysis
Frequently Asked Questions
- Q: What percentage of Ken-Ya shares has Johnson accumulated?
- A: Johnson has announced that it has accumulated a holding of 22.94% in Ken-Ya shares.
- Q: Why did Johnson increase its shareholding in Ken-Ya?
- A: The increase aims to protect investment rights, respond to Ken-Ya's share swap merger with i-Vee, and share complementary resources.
- Q: What core competitiveness does Ken-Ya possess in the strategic layout?
- A: Ken-Ya has core competitiveness in niche new drug R&D, sustained-release formulation development, and high-quality injectable production.
- Q: What is the details of Johnson's proposed stock split plan?
- A: The plan is a 'one-for-two' stock split adjusting the par value per share from NT$10 to NT$5, doubling the number of shares.
- Q: When will the proposed stock split plan of Johnson be executed?
- A: The stock split plan is to be executed upon approval by the company's shareholders' meeting.